Summary | Mutation origin | Mutation description | Expression | Phenotypes | Find Mice (IMSR) | References

Symbol: Stard13tm1Ioln Name: StAR related lipid transfer domain containing 13; targeted mutation 1, Irene Oi Lin Ng MGI ID: MGI:4359214 Synonyms: DLC2- Gene: Stard13  Location: Chr5:150960975-151157301 bp, - strand  Genetic Position: Chr5, 89.82 cM Alliance: Stard13tm1Ioln page

Decrease in adipose fat in Stard13tm1Ioln/Stard13tm1Ioln mice Show the 1 phenotype image(s) involving this allele.

Germline Transmission:	Earliest citation of germline transmission: J:152475
Parent Cell Line:	AB2.2 (ES Cell)
Strain of Origin:	129S7/SvEvBrd-Hprt1b-m2

Allele Type:    Targeted (Null/knockout) Mutations:    Insertion, Intragenic deletion   Mutation details: Exon 5 was replaced with a neo cassette. The absence of transcript expression was confirmed by RT-PCR analysis on heart, liver, and skeletal muscle extracts. (J:152475)

Generation of the Stard13tm1Ioln allele

View phenotypes and curated references for all genotypes (concatenated display).

In Structures Affected by this Mutation:

2 anatomical structure(s)

Mouse strains and cell lines available from the International Mouse Strain Resource (IMSR)
Carrying this Mutation:	Mouse Strains: 0 strains available      Cell Lines: 0 lines available
Carrying any Stard13 Mutation:	54 strains or lines available

Original:	J:152475 Yau TO, et al., Deleted in liver cancer 2 (DLC2) was dispensable for development and its deficiency did not aggravate hepatocarcinogenesis. PLoS One. 2009;4(8):e6566
All:	3 reference(s)